Navigation Links
Increased Demand for Visual Healthcare ADE Prevention Platform
Date:5/18/2011

RENO, Nev., May 18, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a direct response to the Obama administration 1 billion dollar patient-safety program aimed at reducing preventable medical errors.

The stand alone version, still running on an Oracle (ORCL) data base, will be installed in a matter of weeks and operational immediately as it requires minimal training for clinicians. The resulting cost savings are passed on to the hospital which can then recoup its investment in less than a year. Adverse drug events represent a serious financial concern as they cost an average of some $7,000 per case, adding up to an annual burden in the millions.

"We will be signing deals in the next 30 days which could have an impact as early as the current quarter," says Chairman Gerard Dab.  "Pressure from the White House is having a strong impact on the marketplace. Early adopters seeking to move ahead will be signing some 20 deals having a value of more than 15M in the next 12 months. Subsequently as budgets increase, growth of this product line will continue to be exponential," concludes Mr. Dab.

This watershed program follows the publishing of a study showing that one in three patients admitted to hospitals suffers a medical error or accident. Through this program, President Obama is challenging hospitals to dramatically cut mistakes and readmissions due to preventable errors or negligence by 40 percent and cutting preventable hospital readmissions by 20 percent. The first tranche of 1 billion is being funneled to the industry under the Patient Protection and Affordable Act.

"Reducing the massive incidence of drug errors in hospital can only be achieved by automation and using smart systems like ours,"
'/>"/>

SOURCE Visual Healthcare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Two New Studies in the British Medical Journal Find That Bayers Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot
2. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
3. CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
4. Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes
5. MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan
6. New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
7. Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days
8. Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction
9. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
10. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
11. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
(Date:8/31/2015)... 2015 BioLight Life ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, today announced that its cancer ... several new genetic markers with high potential to ... with bisphosphonate drugs and was able to repeat ...
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
Breaking Medicine Technology:Diplomat to Participate in Upcoming Investor Conferences 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
(Date:8/31/2015)... ... 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored a ... Mendon, IL. The purpose behind this concert was to raise money for music education ... Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of the ...
(Date:8/31/2015)... ... August 31, 2015 , ... "While working as an ... effectively deliver oxygen with a lower risk of failure," explained an inventor, from ... the Adam Device." , The Adam Device offers a quick, effective and predictable ...
(Date:8/31/2015)... ... August 31, 2015 , ... Westchester ... Grand Prairie, is teaming up with the Tarrant County chapter of Meals on ... on Wheels is the oldest and largest national organization that supports the more ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like coming home. Life-long ... of Geneva. During his first days on the job, he’s run into residents of ... and I like knowing that they’re living in such a wonderful place,” he said. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Now here’s some ... advice to "make at least half your grains whole,” with the majority of Americans ... Oldways Whole Grains Council (WGC) released these findings and others from the ...
Breaking Medicine News(10 mins):Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5
... a one in eight lifetime risk that a woman will ... remains early detection. Now, Women & infants Hospital of Rhode ... level with the installation of the most advanced imaging technology ... the first and only facility in southeastern New England to ...
... effort to replace animal fat in hot dogs, sausages, hamburgers ... advance in solving the mystery of why hot dogs develop ... animal fat. A report on their study appears in ACS, ... M. Herrero and colleagues explain that some brands of sausage ...
... proven the continuing effectiveness of treating patients with ... acid in addition to adjuvant endocrine treatment including ... Austrian Breast & Colorectal Cancer Study Group (ABCSG-12), ... Cancer Symposium, held Dec. 6-10, 2011, confirmed and ...
... waves, could stop many victims of major head injury from ... Neurology has found. Scientists have been investigating ... now of keen interest to the U.S. military because head ... in Iraq and Afghanistan. Researchers at King,s College London ...
... 2011 A research team led by scientists at the Chinese ... how a bacterium, Helicobacter pylori , that causes more than ... stomach cancer has managed for eons to turn the acidic environment ... Writing in a Journal of Biological Chemistry "Paper ...
... Post-menopausal women with hormone receptor-positive metastatic breast cancer ... their lives, according to results of a study by ... the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. ... fulvestrant used in the SWOG S0226 trial extended the ...
Cached Medicine News:Health News:Hospital gives first tomosynthesis mammograms in region this week 2Health News:Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 3Health News:Closing in on an ulcer- and cancer-causing bacterium 2Health News:Closing in on an ulcer- and cancer-causing bacterium 3Health News:Anti-estrogen combo better than single drug for hormone-sensitive breast cancer 2
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
... Normal and Abnormal ... Assays of vWF, D-dimer ... on STA© Analyzers. For ... vWF (#0518),STA© LIATEST© D-DI ...
CRP high sensitivity calibrator series...
Inquire...
Medicine Products: